Literature DB >> 19523618

Comparison of GnRH antagonist protocol with or without oral contraceptive pill pretreatment and GnRH agonist low-dose long protocol in low responders undergoing IVF/intracytoplasmic sperm injection.

Chung-Hoon Kim1, Gyun-Ho Jeon, Yong-Pil Cheon, Ilkyung Jeon, Sung-Hoon Kim, Hee-Dong Chae, Byung-Moon Kang.   

Abstract

This prospective randomized study was performed to compare the efficacy of GnRH antagonist multiple-dose protocol (MDP) with or without oral contraceptive pill (OCP) pretreatment and GnRH agonist low-dose long protocol (LP) in 82 patients undergoing IVF/intracytoplasmic sperm injection (ICSI). GnRH antagonist MDP with OCP pretreatment was at least as effective as GnRH agonist low-dose LP in low responders, and can benefit the low responders by reducing the amount of FSH and the number of days of stimulation required for follicular maturation.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19523618     DOI： 10.1016/j.fertnstert.2009.05.013

Source DB:  PubMed          Journal:  Fertil Steril        ISSN： 0015-0282            Impact factor:   7.329


  8 in total

1.  Does the degree of hypothalamic-pituitary-ovarian recovery after oral contraceptive pills affect outcomes of IVF/ICSI cycles receiving GnRH-antagonist adjuvant therapy in women over 35 years of age?

Authors:  Carla Schmitz; Silvina Bocca; Hind Beydoun; Laurel Stadtmauer; Sergio Oehninger
Journal:  J Assist Reprod Genet       Date:  2012-06-23       Impact factor: 3.412

2.  Defining ovarian reserve to better understand ovarian aging.

Authors:  Norbert Gleicher; Andrea Weghofer; David H Barad
Journal:  Reprod Biol Endocrinol       Date:  2011-02-07       Impact factor: 5.211

3.  Optimal Candidates to Do Fresh Embryo Transfer in Those Using Oral Contraceptive Pretreatment in IVF Cycles.

Authors:  Yao Lu; Yichao Niu; Yuan Wang; Yaqiong He; Ying Ding; Xinyuan Lu; Bing Xu; Steven R Lindheim; Yun Sun
Journal:  Front Physiol       Date:  2021-03-11       Impact factor: 4.566

Review 4.  Ovarian Stimulation in Assisted Reproductive Technology Cycles for Varied Patient Profiles: An Indian Perspective.

Authors:  Padma Rekha Jirge; Madhuri Milind Patil; Rohit Gutgutia; Jatin Shah; Mridubhashini Govindarajan; Varsha Samson Roy; Nalini Kaul-Mahajan; Faddy I Sharara
Journal:  J Hum Reprod Sci       Date:  2022-06-30

Review 5.  Optimal usage of the GnRH antagonists: a review of the literature.

Authors:  Alan B Copperman; Claudio Benadiva
Journal:  Reprod Biol Endocrinol       Date:  2013-03-15       Impact factor: 5.211

6.  The effect of aromatase inhibitor letrozole incorporated in gonadotrophin-releasing hormone antagonist multiple dose protocol in poor responders undergoing in vitro fertilization.

Authors:  Kyung-Hee Lee; Chung-Hoon Kim; Hye-Jin Suk; You-Jeong Lee; Su-Kyung Kwon; Sung-Hoon Kim; Hee-Dong Chae; Byung-Moon Kang
Journal:  Obstet Gynecol Sci       Date:  2014-05-15

7.  Pretreatment with oral contraceptive pills to identify poor responders that may benefit from rLH supplementation during GnRH-antagonist treatment for IVF: A pilot perspective study proposal.

Authors:  Salvatore Gizzo; Alessandra Andrisani; Marco Noventa; Michele Gangemi; Giovanni Battista Nardelli; Guido Ambrosini
Journal:  Exp Ther Med       Date:  2015-09-08       Impact factor: 2.447

8.  Fresh and cumulative live birth rates in mild versus conventional stimulation for IVF cycles in poor ovarian responders: a systematic review and meta-analysis.

Authors:  Pedro Montoya-Botero; Panagiotis Drakopoulos; Iñaki González-Foruria; Nikolaos P Polyzos
Journal:  Hum Reprod Open       Date:  2021-02-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.